Status Epileptikus Tablosu İle Başvuran Hastada Tespit Edilen Takayasu Hastalığı

Nabızsızlık hastalığı olarak bilinen Takayasu Arteriti (TA) hafif semptomlarla kendini ortaya koyabileceği gibi hastalığın ilerlemesine bağlı olarak ağır komplikasyonlara da neden olabilir. TA öncelikli olarak karotis, subklavyen, vertebral, renal ve aorta gibi büyük arterleri tutar. Aynı zamanda koroner ve pulmoner arterleri de tutabilen kronik bir vaskülittir. Başlangıçta ateş, halsizlik, gece terlemesi, kilo kaybı, miyalji, baş dönmesi ve senkop gibi nonspesifik bulgularla seyrettiği için tanıda gecikmeler olabilir. Bu yüzden özellikle genç kadınlarda vaskülit farkındalığı önem arz etmektedir. Biz bu olguda durdurulamayan epileptik nöbet ile hastaneye başvuran ve mekanik ventilasyon desteği için yoğun bakım ünitesinde takip edilen hastamızda tespit ettiğimiz TA’yı sunmayı amaçladık.

Anahtar Kelimeler:

takayasu, status epileptikus, arterit

A Case of Takayasu Arteritis Diagnosed in a Patient Presenting with Status Epilepticus

Takayasu Arteritis (TA), also known as pulsless disease, can manifest itself with mild symptoms or cause severe complications depending on the progression of the disease. TA primarily involves large arteries such as carotid, subclavian, vertebral, renal and aorta. It is a chronic vasculitis that can also involve the coronary and pulmonary arteries. There may be delays in diagnosis since it initially presents with nonspecific findings such as fever, weakness, night sweats, weight loss, myalgia, dizziness and syncope. Therefore, awareness of vasculitis is important especially in young women. In this case, we aimed to present our patient who was admitted to the hospital with a persistent epileptic seizure and followed up in the intensive care unit for mechanical ventilation support. Then he has been diagnosed with TA during his clinical management.

Keywords:

Status epilepticus, takayasu, arteritis,

PDF

___

Numano F. Thestory of Takayasu arteritis. Rheumatology (Oxford). 2002;41:103–6. doi:10.1093/rheumatology/41.1.103
Oner FA, Direskeneli H. Update on Takayasu's arteritis. La Presse Medicale. 2015;44:259-65. doi:10.1016/j.lpm.2015.01.015
Keser G, Aksu K. Dirençli Takayasu arteriti tedavisi. Management of resistantTakayasu arteritis. RAED Dergisi. 2011;3(1-2):20-28. doi:10.2399/raed.11.004
Koike H, Ashizawa K, Hayashi H, et al. Takayasu Arteritis Presenting as Unexplained Pulmonary Consolidation: A Case Report. Vasc Endovascular Surg. 2018;52(7):579-82. doi:10.1177/1538574418775186
Gümüşçü F, Benli ED, Demirtaş S, Karahan O. A case with late clinical presentation of Takayasu’s arteritis. Dicle Tıp Derg. 2014;41(2):421-24. doi:10.5798/diclemedj.0921.2014.02.0445
Barra L, Yang G, Pagnoux C, The Canadian Vasculitis Network (CanVasc). Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis. Autoimmunity Reviews. 2018;17(7):683–93. doi:10.1016/j.autrev.2018.01.019
Sun Y, Huang Q, Jiang L. Radiology and biomarkers in assessing disease activity in Takayasu arteritis. International Journal of Rheumatic Diseases. 2019;Jan;22 Suppl1:53-59. doi:10.1111/1756-185x.13286
Mason JC. Takayasu arteritis-advances in diagnosis and management. Nat Rev Rheumatol 2010;6(7):406-15. doi:10.1038/nrrheum.2010.82
Schmidt J, Kermani TA, Bacani AK, et al. Diagnosticfeatures, treatment, andoutcomes of Takayasu arteritis in a US cohort of 126 patients. Mayo Clin Proc 2013;88(8):822–30.doi:10.1016/j.mayocp.2013.04.025